SCHEMBL504005

SCHEMBL504005

CC(C)(C)OC(=O)N(c1ccccc1)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.55
TDP1 Q9NUW8 2/20 0.55
ATM Q13315 1/20 0.55
NPSR1 Q6W5P4 4/20 0.50
CHRM4 P08173 4/20 0.49
CHRM3 P20309 4/20 0.49
GSK3B P49841 1/20 0.47
CHRM5 P08912 3/20 0.46
CHRM1 P11229 3/20 0.46
MT-CO2 P00403 1/20 0.44
CHRM2 P08172 1/20 0.44
KMT2A Q03164 4/20 0.43
MEN1 O00255 3/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
RAB9A P51151 2/20 0.42
ALDH1A1 P00352 2/20 0.42
NPC1 O15118 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13148766 0.93 TDP1 (0.49) L3MBTL1TDP1ATMNPSR1CHRM4
SCHEMBL13148723 0.93 TDP1 (0.49) L3MBTL1TDP1ATMNPSR1CHRM4
SCHEMBL13148775 0.93 TDP1 (0.49) L3MBTL1TDP1ATMNPSR1CHRM4
SCHEMBL30073325 0.90 F2 (0.47) L3MBTL1TDP1ATMNPSR1CHRM4
SCHEMBL7928008 0.90 TDP1 (0.46) L3MBTL1TDP1ATMNPSR1CHRM4
SCHEMBL27773374 0.90 MT-CO2 (0.58) L3MBTL1TDP1ATMNPSR1CHRM4
SCHEMBL28440815 0.90 ATM (0.46) L3MBTL1TDP1ATMNPSR1CHRM4
SCHEMBL29966052 0.90 TDP1 (0.46) L3MBTL1TDP1ATMNPSR1CHRM4
SCHEMBL5605319 0.88 ATM (0.45) L3MBTL1TDP1ATMNPSR1CHRM4
SCHEMBL16965122 0.88 ATM (0.55) L3MBTL1TDP1ATMNPSR1CHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 244 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026100259-A1 RADIATION-SENSITIVE COMPOSITION, PATTERN FORMATION METHOD, AND COMPOUND JSR株式会社 2026-05-15 WO disclosed
WO-2026100281-A1 RADIATION-SENSITIVE COMPOSITION, PATTERN FORMATION METHOD, RADIATION-SENSITIVE ACID GENERATOR, AND COMPOUND JSR株式会社 2026-05-15 WO disclosed
WO-2026100258-A1 RADIATION-SENSITIVE COMPOSITION, PATTERN FORMATION METHOD, AND COMPOUND JSR株式会社 2026-05-15 WO disclosed
WO-2026100524-A1 RADIATION-SENSITIVE COMPOSITION, PATTERN FORMING METHOD, ONIUM SALT COMPOUND, AND POLYMER JSR株式会社 2026-05-15 WO disclosed
WO-2026100282-A1 RADIATION-SENSITIVE COMPOSITION, PATTERN FORMING METHOD, POLYMER, AND ONIUM SALT JSR株式会社 2026-05-15 WO disclosed
US-20260079396-A1 RADIATION-SENSITIVE COMPOSITION, METHOD FOR FORMING PATTERN AND ONIUM SALT COMPOUND JSR CORPORATION (JP) 2026-03-19 US disclosed
US-20260063994-A1 RADIATION-SENSITIVE COMPOSITION, METHOD FOR FORMING PATTERN AND ONIUM SALT COMPOUND JSR CORPORATION (JP) 2026-03-05 US disclosed
US-12517429-B2 Radiation-sensitive resin composition and method for forming pattern JSR CORPORATION (JP) 2026-01-06 US disclosed
US-20250377590-A1 RADIATION-SENSITIVE RESIN COMPOSITION AND METHOD FOR FORMING RESIST PATTERN JSR CORPORATION (JP) 2025-12-11 US disclosed
US-20250362596-A1 RADIATION-SENSITIVE COMPOSITION, METHOD FOR FORMING PATTERN, AND RADIATION-SENSITIVE ACID GENERATOR JSR CORPORATION (JP) 2025-11-27 US disclosed
US-20020172885-A1 Novel carbazole derivative and chemically amplified radiation-sensitive resin composition JSR CORPORATION (JP) 2002-11-21 US disclosed
EP-1253470-A2 Radiation-sensitive resin composition JSR Corporation (JP) 2002-10-30 EP disclosed
EP-1238972-A1 Novel carbazole derivative and chemically amplified radiation-sensitive resin composition JSR Corporation (JP) 2002-09-11 EP disclosed
US-6194580-B1 REACTING CARBOXYLIC ACID DERIVATIVE WITH CONDENSING AGENT SUCH AS DICYCLOHEXYCARBODIMIDE FORM ACYL HETEROAROMATIC COMPOUND; REACTING WITH CAMPTOTHECIN AND CAMPTOTHECIN DERIVATIVE IN PRESENCE LANTHANIDE METAL CATALYST TO FORM ESTER COMPOUND ENZON, INC. 2001-02-27 US disclosed
US-6111107-A FORMING ESTERS OF CAMPTOTHECIN OR CAMPTOTHECIN DERIVATIVES BY ACYLATION WITH AN ACYL HETEROAROMATIC ION-BASED COMPOUND USING A LANTHANIDE METAL-BASED CATALYST; PRODRUGS; STEREOSELECTIVE ENZON, INC. (US) 2000-08-29 US disclosed
CN-1050835-C 1, 5-benzodiazepine * derivatives, their preparation and their pharmaceutical use GLAXO SPA (IT) 2000-03-29 CN disclosed
CN-1239952-A 6-phenylpyridyl-2-amine derivatives useful as NOS inhibitors PFIZER (US) 1999-12-29 CN disclosed
CN-1138853-A 1,5-benzodiazepine derivatives useful as CCK or gastrin antagonists GLAXO SPA (IT) 1996-12-25 CN disclosed
EP-0647632-A1 NOVEL BENZODIAZEPINE DERIVATIVE YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1995-04-12 EP disclosed
US-5153226-A Administering as anticholesterol agents, for atherosclerosis WARNER-LAMBERT COMPANY (US) 1992-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260079396-A1 RADIATION-SENSITIVE COMPOSITION, METHOD FOR FORMING PATTERN AND ONIUM SALT COMPOUND SRMS, RAD1, SLC11A2 L3MBTL1 1915/4885TDP1 1266/4885ATM 7/4885
US-20250362596-A1 RADIATION-SENSITIVE COMPOSITION, METHOD FOR FORMING PATTERN, AND RADIATION-SENSITIVE ACID GENERATOR RAD1, RER1, RPA1 L3MBTL1 1809/4885TDP1 521/4885ATM 886/4885
US-20020172885-A1 Novel carbazole derivative and chemically amplified radiation-sensitive resin composition ARID2, RAD1, RAD51 L3MBTL1 2178/4885TDP1 958/4885ATM 1108/4885
US-20260063994-A1 RADIATION-SENSITIVE COMPOSITION, METHOD FOR FORMING PATTERN AND ONIUM SALT COMPOUND RAD1, RPA1, RAD51 L3MBTL1 706/4885TDP1 2310/4885ATM 191/4885
US-20250377590-A1 RADIATION-SENSITIVE RESIN COMPOSITION AND METHOD FOR FORMING RESIST PATTERN RER1, RAD51, RFC2 L3MBTL1 2439/4885TDP1 1960/4885ATM 523/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.